
HeartSciences fell 32.3% from $3.00 to $2.03, behind the S&P 500's +8.0%. Its worst day was Nov 21 (−18.9%), and its low came May 29 at $1.66.
Nov 19, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
HeartSciences shares fell 18.9%, while the S&P 500 rose 1.0%.
−18.9%, the year's worst day · S&P 500 +1.0%
EPS of $-0.85 beat the $-1.12 estimate on $2,419.00 revenue (est. $50,000.00).
Story events cover the past 12 months · Times ET
−6.5% · S&P 500 −0.3%
EPS of $-0.63 beat the $-1.12 estimate on $0.00 revenue (est. $200,000.00).
0.0% · S&P 500 +0.3%
HeartSciences closed at its lowest level of the year, 44.7% below where the year started.
−8.3% · S&P 500 +0.2%
HeartSciences shares rose 55.4%, while the S&P 500 fell 1.5%.
+55.4%, the year's best day, on 136M shares, the year's heaviest volume · S&P 500 −1.5%
EPS of $-0.87 missed the $-0.68 estimate on $0.00 revenue (est. $20,000.00).
−2.0% · S&P 500 +0.1%
HeartSciences shares rose 19.5%, while the S&P 500 rose 0.2%.
+19.5% · S&P 500 +0.2%
EPS of $-0.86 missed the $-0.73 estimate on $2,100.00 revenue (est. $20,000.00).
−2.8% · S&P 500 −0.5%
Where it ended: a close of $2.03 on Nov 19, 2026. Up next: Q2 2027 earnings on Dec 14, 2026 (EPS est. $-0.64, revenue est. $20,000.00).
Nothing in the past 12 months.
All HSCS dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HSCS and SPY from Benzinga historical bars. Not investment advice.